Formulation Isn’t a One-Time Cost
Teams rarely get a functional gummy right on the first attempt. Flavor masking, texture adjustments and stability testing drive multiple iterations. Each round adds cost and delays timelines. Brands that underestimate this phase often enter production already behind on margin.
Yield Loss Adds Up Quickly
Small inefficiencies compound. Inconsistent batches, ingredient loss and rework reduce overall yield. These losses don’t always appear in initial costings, but they directly impact profitability at scale.
Complexity Drives Cost
More actives, higher claims, and cleaner labels increase formulation difficulty. Each added requirement introduces constraints in processing and stability. Strong products balance ambition with manufacturability—otherwise, costs escalate without improving commercial performance.
These constraints also sit within broader regulatory frameworks governing dietary supplements, as outlined by the FDA – FDA Dietary Supplements Overview.
Time Is a Cost Driver
Delays in development or production don’t just affect timelines, they affect revenue. Missed launch windows, extended testing phases and slow scale-up all reduce return on investment.
Ingredient approvals, additive standards and formulation compliance, guided by bodies such as the FDA, can further influence timelines and cost structures.
Done is better than Perfect
Margins in gummy manufacturing aren’t decided at launch. They are shaped across every stage of development and production. Brands that understand where costs accumulate, and act early – build products that scale profitably. Looking to optimise your formulation and manufacturing strategy? Work with us to build products designed for both performance and scale.
